A <i>JAK2</i>/<i>IDH1</i>-mutant MPN clone unmasked by ivosidenib in an AML patient without antecedent MPN
Wenbin Xiao(Memorial Sloan Kettering Cancer Center), Sheng F. Cai(Memorial Sloan Kettering Cancer Center), Helen S. Tian(Molecular Oncology (United States)), Linde A. Miles(Memorial Sloan Kettering Cancer Center), Nicole L. DelGaudio(Cancer Services), Robert L. Bowman(University of Pennsylvania), Vidushi Durani(Manhattan Scientifics (United States)), Tanmay Mishra(Vellore Institute of Technology University), Menglei Zhu, Sarah E. Stump, Martin S. Tallman(Memorial Sloan Kettering Cancer Center), Yanming Zhang(Memorial Sloan Kettering Cancer Center), Ross L. Levine(Memorial Sloan Kettering Cancer Center)
Cited by 5
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
The landscape of somatic copy-number alteration across human cancers
|Nature|2010|4.1k